Neurocrine Biosciences Inc
Market cap $15.4B
$151.83
NBIX
$151.83
+1.56% today
Buy with €1M virtual cash · No real money
Neurocrine Biosciences Inc (NBIX) is a publicly traded company listed on the XNAS. As of September 18, 2026, Invest's signal rates NBIX a Buy, with the stock up 8% over the past year. You can practice trading NBIX risk-free with €1,000,000 in virtual cash.
Key stats
As of September 18, 2026
Market Cap
$15.4B
Volume
1.2M
52-wk High
$186.12
52-wk Low
$122.14
Day High
$152.07
Day Low
$149.71
P/E (TTM)
22.26
Revenue (TTM)
$3.4B
EPS (TTM)
$6.82
Performance
1M
-1.6%
6M
+16.2%
1Y
+7.8%
Invest signal · NBIX
BuyAlgorithmic signal from price trend, valuation, and fundamentals — educational only, not financial advice.
NBIX overview
AI overviewRevenue & EPS — last 8 quarters
QoQ rev +17.7%Revenue
$959MEPS (diluted)
$1.39 per shareLatest NBIX news
Nxera Pharma’s Partner Neurocrine Biosciences Receives IND Acceptance from the FDA for Phase 2 Study of NBI-1117567 for Alzheimer's Cognition
GlobeNewswire Inc. · Aug 26
Nxera Pharma Operational Highlights and Consolidated Results for the Second Quarter 2026
GlobeNewswire Inc. · Aug 7
Tom Lee's Small-Cap Granny Shots ETF Reloads: First Solar, Zoom Among 10 New Buys
Benzinga · Jun 10
Nxera Pharma Operational Highlights and Consolidated Results for the First Quarter 2026
GlobeNewswire Inc. · May 1
Nxera Pharma’s Partner Neurocrine Biosciences Doses First Patient in Phase 2 Trial of NBI-1117570 for Adults with Schizophrenia
GlobeNewswire Inc. · Apr 12
About Neurocrine Biosciences Inc
Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies.
It derives revenue from the sale of its pharmaceutical products.
Employees
2,500
30-Day Win Rate · NBIX
12 days
11 days
Last 23 sessions
How to practice trading NBIX
- 1
Use the NBIX buy panel above
Set a quantity and hit Buy at the real market price — right here, nothing to download.
- 2
Trade with €1,000,000 virtual cash
You get a million in virtual money instantly to invest, risk-free.
- 3
Create a free account to save it
Sign up in seconds to keep your portfolio and track its performance.
- 4
Track and compete
Watch your portfolio grow and climb the global leaderboard — or start a private league.
- 5
Prefer mobile? Get the iOS app
Invest is also free on the App Store, synced with your web account.
Top NBIX traders on Invest
Full leaderboardFrequently asked questions
Is NBIX a good stock to buy right now?
As of September 18, 2026, Invest's signal rates NBIX a Buy, based on its price trend, valuation, and fundamentals (P/E around 22.3), with the stock up 8% over the past year. This is an educational signal, not financial advice — the best way to test the thesis is to practice trading NBIX risk-free first.
What is Neurocrine Biosciences Inc's (NBIX) market cap?
Neurocrine Biosciences Inc has a market capitalization of approximately $15.4B, on trailing-twelve-month revenue of about $3.4B.
How has NBIX stock performed?
NBIX is up 8% over the past year and up 16% over six months. Its 52-week range runs roughly from $122.14 to $186.12. Past performance doesn't predict future results.
How can I practice trading NBIX for free?
On Invest you get €1,000,000 in virtual cash and can buy NBIX at real market prices right in your browser — no download and no real money at risk. Create a free account to save your portfolio and track its performance over time.
More stocks to practice
Designs the iPhone, Mac, and a huge services ecosystem.
Windows, Office, Azure cloud, and enterprise software.
The leading designer of AI and gaming GPUs.
E-commerce giant and the largest cloud provider (AWS).
Google Search, YouTube, Android, and cloud.
Facebook, Instagram, WhatsApp, and the metaverse.
Compare NBIX with peers